Cargando…

METFORMIN CONTINUATION VERSUS INTERRUPTION FOLLOWING CORONARY ANGIOGRAPHY: CONTEMPORARY RISK OF LACTIC ACIDOSIS. A PILOT SINGLE-CENTER RANDOMIZED CONTROL TRIAL

Detalles Bibliográficos
Autores principales: Shavadia, J., Minhas, R., Orvold, J., Basran, R., Wells, C., Devilliers, J., Pearce, C., Eckstein, J., Pausjenssen, E., Haddad, H., Mangipudi, R., Rana, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529404/
http://dx.doi.org/10.1016/j.cjca.2020.07.214
_version_ 1783589429043003392
author Shavadia, J.
Minhas, R.
Orvold, J.
Basran, R.
Wells, C.
Devilliers, J.
Pearce, C.
Eckstein, J.
Pausjenssen, E.
Haddad, H.
Mangipudi, R.
Rana, M.
author_facet Shavadia, J.
Minhas, R.
Orvold, J.
Basran, R.
Wells, C.
Devilliers, J.
Pearce, C.
Eckstein, J.
Pausjenssen, E.
Haddad, H.
Mangipudi, R.
Rana, M.
author_sort Shavadia, J.
collection PubMed
description
format Online
Article
Text
id pubmed-7529404
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-75294042020-10-02 METFORMIN CONTINUATION VERSUS INTERRUPTION FOLLOWING CORONARY ANGIOGRAPHY: CONTEMPORARY RISK OF LACTIC ACIDOSIS. A PILOT SINGLE-CENTER RANDOMIZED CONTROL TRIAL Shavadia, J. Minhas, R. Orvold, J. Basran, R. Wells, C. Devilliers, J. Pearce, C. Eckstein, J. Pausjenssen, E. Haddad, H. Mangipudi, R. Rana, M. Can J Cardiol Article Published by Elsevier Inc. 2020-10 2020-10-01 /pmc/articles/PMC7529404/ http://dx.doi.org/10.1016/j.cjca.2020.07.214 Text en Copyright © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Shavadia, J.
Minhas, R.
Orvold, J.
Basran, R.
Wells, C.
Devilliers, J.
Pearce, C.
Eckstein, J.
Pausjenssen, E.
Haddad, H.
Mangipudi, R.
Rana, M.
METFORMIN CONTINUATION VERSUS INTERRUPTION FOLLOWING CORONARY ANGIOGRAPHY: CONTEMPORARY RISK OF LACTIC ACIDOSIS. A PILOT SINGLE-CENTER RANDOMIZED CONTROL TRIAL
title METFORMIN CONTINUATION VERSUS INTERRUPTION FOLLOWING CORONARY ANGIOGRAPHY: CONTEMPORARY RISK OF LACTIC ACIDOSIS. A PILOT SINGLE-CENTER RANDOMIZED CONTROL TRIAL
title_full METFORMIN CONTINUATION VERSUS INTERRUPTION FOLLOWING CORONARY ANGIOGRAPHY: CONTEMPORARY RISK OF LACTIC ACIDOSIS. A PILOT SINGLE-CENTER RANDOMIZED CONTROL TRIAL
title_fullStr METFORMIN CONTINUATION VERSUS INTERRUPTION FOLLOWING CORONARY ANGIOGRAPHY: CONTEMPORARY RISK OF LACTIC ACIDOSIS. A PILOT SINGLE-CENTER RANDOMIZED CONTROL TRIAL
title_full_unstemmed METFORMIN CONTINUATION VERSUS INTERRUPTION FOLLOWING CORONARY ANGIOGRAPHY: CONTEMPORARY RISK OF LACTIC ACIDOSIS. A PILOT SINGLE-CENTER RANDOMIZED CONTROL TRIAL
title_short METFORMIN CONTINUATION VERSUS INTERRUPTION FOLLOWING CORONARY ANGIOGRAPHY: CONTEMPORARY RISK OF LACTIC ACIDOSIS. A PILOT SINGLE-CENTER RANDOMIZED CONTROL TRIAL
title_sort metformin continuation versus interruption following coronary angiography: contemporary risk of lactic acidosis. a pilot single-center randomized control trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529404/
http://dx.doi.org/10.1016/j.cjca.2020.07.214
work_keys_str_mv AT shavadiaj metformincontinuationversusinterruptionfollowingcoronaryangiographycontemporaryriskoflacticacidosisapilotsinglecenterrandomizedcontroltrial
AT minhasr metformincontinuationversusinterruptionfollowingcoronaryangiographycontemporaryriskoflacticacidosisapilotsinglecenterrandomizedcontroltrial
AT orvoldj metformincontinuationversusinterruptionfollowingcoronaryangiographycontemporaryriskoflacticacidosisapilotsinglecenterrandomizedcontroltrial
AT basranr metformincontinuationversusinterruptionfollowingcoronaryangiographycontemporaryriskoflacticacidosisapilotsinglecenterrandomizedcontroltrial
AT wellsc metformincontinuationversusinterruptionfollowingcoronaryangiographycontemporaryriskoflacticacidosisapilotsinglecenterrandomizedcontroltrial
AT devilliersj metformincontinuationversusinterruptionfollowingcoronaryangiographycontemporaryriskoflacticacidosisapilotsinglecenterrandomizedcontroltrial
AT pearcec metformincontinuationversusinterruptionfollowingcoronaryangiographycontemporaryriskoflacticacidosisapilotsinglecenterrandomizedcontroltrial
AT ecksteinj metformincontinuationversusinterruptionfollowingcoronaryangiographycontemporaryriskoflacticacidosisapilotsinglecenterrandomizedcontroltrial
AT pausjenssene metformincontinuationversusinterruptionfollowingcoronaryangiographycontemporaryriskoflacticacidosisapilotsinglecenterrandomizedcontroltrial
AT haddadh metformincontinuationversusinterruptionfollowingcoronaryangiographycontemporaryriskoflacticacidosisapilotsinglecenterrandomizedcontroltrial
AT mangipudir metformincontinuationversusinterruptionfollowingcoronaryangiographycontemporaryriskoflacticacidosisapilotsinglecenterrandomizedcontroltrial
AT ranam metformincontinuationversusinterruptionfollowingcoronaryangiographycontemporaryriskoflacticacidosisapilotsinglecenterrandomizedcontroltrial